India’s Food Regulator Challenges a GLP-1 Protein Drink From Dr Reddy’s and Nestle Health Science

FSSAI has issued show-cause notices over Celevida GLP+, flagging claims about preserving lean muscle during GLP-1 therapy. Amazon, Flipkart and Netmeds were also served.











